テキサスにおける乾癬の臨床試験
テキサス内の拠点で、乾癬に関する8件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
- Precision Comprehensive Research, Colleyville
- Rheumatology Associates of South Texas, San Antonio
被験者募集中第2相
18歳〜100歳 · 全性別 · 2026/09/25更新 · NCT07801495Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
- Vanda Investigational Site, San Antonio
- Vanda Investigational Site, Webster
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/22更新 · NCT07362017A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Bellaire Dermatology Associates, Bellaire
- Modern Research Associates, PLLC, Dallas
- Center for Clinical Studies, Houston
- 他3件
被験者募集中第4相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06857942A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Texas Dermatology and Laser Specialists, San Antonio
- Local Institution - 0280, Southlake
被験者募集中第3相
12歳〜17歳 · 全性別 · 2026/09/03更新 · NCT06979453A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
- Study Center, San Antonio
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/07/09更新 · NCT07489885Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/05/20更新 · NCT04751396Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
- Clinical Investigations of Texas, Dallas
被験者募集中第1相
18歳以上 · 全性別 · 2025/12/19更新 · NCT06982352ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。